Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 690

1.

Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.

Chang JY, Zhang X, Wang X, Kang Y, Riley B, Bilton S, Mohan R, Komaki R, Cox JD.

Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1087-96. Epub 2006 May 6.

PMID:
16682145
3.

[Dose distributions of proton beam therapy for hepatocellular carcinoma: a comparative study of treatment planning with 3D-conformal radiation therapy or intensity-modulated radiation therapy].

Li JM, Yu JM, Liu SW, Chen Q, Mu XK, Jiang QA, Zhao MH, Zhang JG.

Zhonghua Yi Xue Za Zhi. 2009 Dec 8;89(45):3201-6. Chinese.

PMID:
20193534
4.

Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer.

Liu HH, Wang X, Dong L, Wu Q, Liao Z, Stevens CW, Guerrero TM, Komaki R, Cox JD, Mohan R.

Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1268-79.

PMID:
15001272
5.

Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.

Chera BS, Rodriguez C, Morris CG, Louis D, Yeung D, Li Z, Mendenhall NP.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1173-80. doi: 10.1016/j.ijrobp.2008.12.048. Epub 2009 Apr 20.

PMID:
19386423
6.

Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.

Murshed H, Liu HH, Liao Z, Barker JL, Wang X, Tucker SL, Chandra A, Guerrero T, Stevens C, Chang JY, Jeter M, Cox JD, Komaki R, Mohan R.

Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1258-67. Erratum in: Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):921. Change, Joe T [corrected to Chang, Joe T].

PMID:
15001271
7.

Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?

Lee CT, Bilton SD, Famiglietti RM, Riley BA, Mahajan A, Chang EL, Maor MH, Woo SY, Cox JD, Smith AR.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):362-72.

PMID:
16168831
8.

Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer.

Schwarz M, Alber M, Lebesque JV, Mijnheer BJ, Damen EM.

Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):561-70.

PMID:
15890601
9.

Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric study.

Nichols RC, Huh SN, Henderson RH, Mendenhall NP, Flampouri S, Li Z, D'Agostino HJ, Cury JD, Pham DC, Hoppe BS.

Clin Lung Cancer. 2011 Jul;12(4):252-7. doi: 10.1016/j.cllc.2011.03.027. Epub 2011 Apr 27.

PMID:
21726825
10.
11.

Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.

Hoppe BS, Flampouri S, Su Z, Morris CG, Latif N, Dang NH, Lynch J, Li Z, Mendenhall NP.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):260-7. doi: 10.1016/j.ijrobp.2011.06.1959. Epub 2011 Oct 17.

PMID:
22014950
12.

Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes.

Lomax AJ, Cella L, Weber D, Kurtz JM, Miralbell R.

Int J Radiat Oncol Biol Phys. 2003 Mar 1;55(3):785-92.

PMID:
12573766
13.

A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.

Weber DC, Trofimov AV, Delaney TF, Bortfeld T.

Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1596-606.

PMID:
15050341
14.

Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.

Yom SS, Liao Z, Liu HH, Tucker SL, Hu CS, Wei X, Wang X, Wang S, Mohan R, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):94-102. Epub 2007 Feb 22.

PMID:
17321067
15.

Postoperative proton radiotherapy for localized and locoregional breast cancer: potential for clinically relevant improvements?

Ares C, Khan S, Macartain AM, Heuberger J, Goitein G, Gruber G, Lutters G, Hug EB, Bodis S, Lomax AJ.

Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):685-97. doi: 10.1016/j.ijrobp.2009.02.062. Epub 2009 Jul 15.

PMID:
19615828
16.

Comparisons of dose-volume histograms for proton-beam versus 3-D conformal x-ray therapy in patients with stage I non-small cell lung cancer.

Wang C, Nakayama H, Sugahara S, Sakae T, Tokuuye K.

Strahlenther Onkol. 2009 Apr;185(4):231-4. doi: 10.1007/s00066-009-1923-x. Epub 2009 Apr 16.

PMID:
19370425
17.

Comparison of inverse-planned three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for non-small-cell lung cancer.

Christian JA, Bedford JL, Webb S, Brada M.

Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):735-41. Epub 2006 Dec 21.

PMID:
17187941
18.

Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer.

Choi Y, Kim JK, Lee HS, Hur WJ, Chai GY, Kang KM.

Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):683-9. Epub 2005 May 31.

PMID:
15927412
19.

Role of IMRT in reducing penile doses in dose escalation for prostate cancer.

Sethi A, Mohideen N, Leybovich L, Mulhall J.

Int J Radiat Oncol Biol Phys. 2003 Mar 15;55(4):970-8.

PMID:
12605975
20.

Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma.

Bradley JD, Ieumwananonthachai N, Purdy JA, Wasserman TH, Lockett MA, Graham MV, Perez CA.

Int J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):49-57.

PMID:
11777621
Items per page

Supplemental Content

Write to the Help Desk